business / news / / India TV News
Shares of Sun Pharmaceutical Industries surged over 9 per cent on Monday, April 27, 2026.
Sun Pharma will acquire Organon & Co. for USD 11.75 billion in an all-cash deal.
KEY POINTS
- This acquisition is one of the largest overseas deals by an Indian firm.
- Sun Pharma will pay USD 14 per Organon share as part of the definitive agreement.
- After the deal, Sun Pharma's combined revenue will reach USD 12.4 billion, entering the top 25 globally.
COMPANIES
Summarized by Newsio from India TV News. How we summarize →